0
2020
Covid-19 Diagnostics Market

Covid-19 Diagnostics Market by Product (PCR Kits, POC Kits and Immunoassay), Technology (Molecular and Immunoassay), and End User (Hospitals, Physician's office & urgent care clinics and Diagnostic Labs): Global Opportunity Analysis and Industry Forecast, 2020–2022
Update Available On-Demand

A06114
Pages: 275
Sep 2020 | 15622 Views
Author(s) : Kavita Joshi, Sagar Mukhekar , Onkar Sumant
Tables: 318
Charts: 39
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

The global Covid-19 diagnostics market generated $73.19 million in the first quarter of 2020, and is anticipated to generate $9,948.19 million in the fourth quarter of 2020. By the end of year 2020, global Covid-19 diagnostics market size is anticipated to reach $17,203.38 million. Currently, world is facing a pandemic situation due to corona virus outbreak, which started back in December 2019, in Wuhan city of China. Covid-19 is an infectious disease caused by a newly discovered coronavirus. The name Covid-19 depicts belonging of the virus to corona virus family, with its first human interaction noticed in 2019. Further, SARS-CoV-2 is a novel strain of coronavirus that has not been previously identified in humans. Corona virus is the term coined to the family of viruses that transmit between animals and humans thus are also known as zoonotic viruses. Moreover, as of 27th March, 2020 the virus outbreak has been confirmed in six continents and more than 197 countries. As per the World Health Organization (WHO), common symptoms of Covid-19 infection include fever, tiredness, and dry cough. In addition, other symptoms of the disease include shortness of breath, sore throat, aches and pains, and diarrhea in few cases, as well as nausea or a runny nose. Moreover, this infection may spread from one person to other person via saliva droplets or discharge from nose, when an infected person coughs or sneezes. The time from exposure of a person to Covid-19 to onset of symptoms is generally between two to fourteen days, with an average of five days.

At present, the most widely used diagnostic test for detection of Covid-19 is reverse transcriptase PCR or RT PCR. PCR is recognized as the gold standard for diagnosis of various infectious agents. The technique has an advantage that the primers required for performing such tests can be produced with relative speed. Moreover, multiplex RT-PCR that has the capability of performing multiple target sequences simultaneously are the most preferred diagnostic tests for Covid-19. In addition, leading manufacturers of diagnostic kits such as Roche Diagnostics, Thermo Fisher Scientific, and Quest Diagnostics are significantly increasing up their capacity to perform such tests by rolling out automated SARS-CoV-2 testing systems. However, few companies such as SureScreen are focusing towards developing rapid immunoassay tests for Covid-19 diagnosis.
 

Covid-19-Diagnostics-Market-2020-2027

Get more information on this report : Request Sample Pages

The major factors that drive the covid-19 market growth include significant increase in patient population across the globe and immense need of rapid diagnostics. Covid-19 has been declared as a pandemic by WHO. On 26 March, 2020, as per WHO, the positive cases of covid-19 across the globe rose to 416,686 with 18,589 deaths. In addition, unavailability of specific medicine or a vaccine propels the covid-19 diagnostics market growth. However, lack of awareness among developing countries regarding the necessary precautions to be taken and dearth of medical professionals that have sufficient knowledge regarding the use of diagnostic kits for novel covid-19 are the major factors anticipated to hamper the growth of covid-19 diagnostics market. On the contrary, leading manufacturers of diagnostic kits can get benefited with several lucrative opportunities by developing rapid diagnostic kits. Further, various local players are also seeking immense opportunities by developing diagnostic kits and assays. For instance, Mylab, India has received approval by the Drug Controller of India for Covid-19 diagnostic kit, after the National Institute of Virology validated its test.

The Covid-19 diagnostics market is segmented on the basis of product, technology, end-users, and region. By product, it is categorized into PCR Kits, POC (point of contact) Kits and immune-assay. By technology, it is segmented into PCR and immunoassay. By end-users it is segmented into hospitals, physician's office & urgent care clinics and diagnostic labs. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Covid-19-Diagnostics-Market-2020-updated-SEG4

Get more information on this report : Request Sample Pages

Technology segment review

On the basis of technology, the PCR segment accounted for 80% of the total share in 2020 and is expected to exhibit a prominent growth rate in the near future, owing to its increased demand for diagnosis of coronavirus patients. In addition PCR is considered as a gold standard in terms of diagnosis of new virus infections. However, immunoassay segment is anticipated to grow at the fastest growth rate during the forecast period. This is attributed to the increased demand for rapid immunoassay tests for disease diagnosis. Many immunoassay test kits are being developed for the confirmation of Sars Cov 2 infections. For instance, qSARS-CoV-2 IgG/IgMtest developed by Cellex Inc.

End User segment review

By end user, the diagnosis labs segment is anticipated to dominate the Covid-19 diagnostics market in 2020, and continue to maintain its dominance throughout the forecast period. This is attributed to the fact that PCR test procedures require a laboratory to be processed as it includes the usage of various kinds of reagents and other instruments as well. 

Key companies working towards the development of rapid diagnostic kits for Covid-19 include F. Hoffmann-La Roche AG, Seegene Inc., Cepheid, Mylab Lifesolutions Pvt. Ltd., SureScreen Diagnostics Ltd, Cellex Inc., Genematrix, Thermo Fisher Scientific, Inc.and Robert Bosch GmbH among others.

Covid-19-Diagnostics-Market-2020-updated-SEG-2

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current Covid-19 diagnostics market trends and forecast estimations from 2020 to 2022, which assists to identify the prevailing market opportunities. 
  • An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the covid-19 market growth is provided.
  • The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2022, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the Covid-19 Diagnostics market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook.

Key Market Segments

  • By Technology
    • Molecular assay
    • Immunoassay/Serology
  • By Product
    • PCR Kits
    • Immunoassay test
    • POC (Point -of-care) test
  • By End User
    • Hospitals
    • Diagnostic laboratories
    • Physician offices & urgent care clinics
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • UK
      • Germany
      • Spain
      • Italy
      • Austria
      • Estonia
      • Czech Republic
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Thailand
      • Malaysia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Israel
      • Rest of LAMEA


Key Market Players

  • ABBOTT LABORATORIES
  • CELLEX INCORPORATED
  • CEPHEID
  • F. HOFFMANN-LA ROCHE LTD.
  • HOLOGIC, INC.
  • LABORATORY CORP OF AMERICA HOLDINGS
  • MYLABDISCOVERY SOLUTIONS PVT. LTD.
  • QUEST DIAGNOSTICS INCORPORATED
  • SEEGENE INC.
  • THERMO FISHER SCIENTIFIC, INC.
 

Loading Table Of Content...


 
 

Covid-19 diagnosis is a contagious disease and is spreading across the globe with fast pace. Hence, there is an urgent requirement for the development of rapid diagnosis tests to prevent widespread of the disease. Moreover, significant ongoing researches are being conducted across the globe to develop rapid diagnosis test kits against Covid-19. Many leading as well small players are focusing toward the development of diagnosis kits that can verify coronavirus infection in its early stage. For instance, on March 12, 2020, Roche Diagnostics, a subsidiary of F. Hoffmann-La Roche AG, a Swiss multinational healthcare company, received the U.S. FDA Emergency Use Authorization for its novel coronavirus diagnostic test kit- Cobas SARS-CoV-2. In addition, an American company, Cepheid developed an automated molecular diagnostic test for qualitative detection of SARS-CoV-2, which has been approved by the U.S. FDA. The test is able to diagnose sars cov 2 infections in around 45 minutes. RT PCR is being considered as the gold standard for diagnosis of the new virus infection.

The Covid-19 diagnostics market is anticipated to witness steady growth during the forecast period, owing to rise in incidences across the globe, surge in diagnosis procedure being performed, and increase in research & development in the field of disease diagnosis. Moreover, increased initiatives to develop rapid diagnosis methods and medical devices for fast disease diagnosis contribute to the market growth

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

 Request Sample
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of Covid 19 Diagnostics Market is $17,203.38 million till the end of 2020.

A. The forcast period for Covid 19 Diagnostics Market is 2020 to 2022.

A. The market value of Covid 19 Diagnostics Market in 2020 is $17,203.38 million.

A. The base year is 2020 in Covid 19 Diagnostics Market

A. Top companies such as, F. Hoffmann-La Roche AG, Seegene Inc., Cepheid, Mylab Lifesolutions Pvt. Ltd., SureScreen Diagnostics Ltd, Thermo Fisher Scientific, Genematrix, and Robert Bosch GmbH among others.

A. Polymerase chain reaction (PCR) Kits segment is the most influencing segment owing to its increased demand for diagnosis of coronavirus patients.

A. The major factor that fuels the growth of the Covid 19 Diagnostics Market includes significant increase in patient population across the globe and immense need of rapid diagnostics. Covid-19 has been declared as a pandemic by WHO. In addition, unavailability of specific medicine or a vaccine propels the covid-19 diagnostics market growth.

A. No, there is no value chain analysis provided in the Covid 19 Diagnostics Market report

A. Covid-19 is an infectious disease caused by a newly discovered coronavirus. The name Covid-19 depicts belonging of the virus to corona virus family, with its first human interaction noticed in 2019.

A. At present, the most widely used diagnostic test for detection of Covid-19 is reverse transcriptase PCR or RT PCR. PCR is recognized as the gold standard for diagnosis of various infectious agents.

RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Covid-19 Diagnostics Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers